Raw material qualification for biologics: what sponsors overlook

Biologics manufacturing depends on a supply chain that is often longer, more fragile, and less transparent than sponsors realize. From cell culture media and chromatography resins to single-use assemblies and water-for-injection systems, every input that contacts the process carries qualification obligations — and regulators expect sponsors to demonstrate control over all of them.

Why raw materials deserve early attention

Many programs defer raw material qualification until late-stage development, treating it as a procurement exercise rather than a scientific one. The consequences tend to arrive during process validation or, worse, during a pre-approval inspection. An unqualified secondary supplier, a missing certificate of analysis, or an undocumented grade change can each trigger a clinical hold or delay filing.

The ICH Q8/Q11 framework emphasizes understanding how input variability affects process performance and product quality. That understanding starts with knowing what you are buying, from whom, and what changes — however minor — have occurred since qualification.

Common blind spots

• Animal-derived materials: Regulatory agencies expect documented risk assessments for TSE/BSE even when the material is several steps removed from the final product.
• Single-use components: Extractables and leachables studies are often incomplete or performed on representative — not actual — assemblies used in production.
• Supplier change notifications: Without a quality agreement that requires advance notice of formulation or manufacturing site changes, sponsors can be caught off guard by subtle shifts in incoming material performance.
• Dual sourcing: Qualifying a second supplier is straightforward in principle but requires demonstrating comparability — not just meeting the same specification.

A specification tells you what to accept. Qualification tells you what to expect — and how to respond when reality deviates from the certificate.

Building a defensible program

A raw material qualification program should be risk-based, documented in a master plan, and integrated with the broader quality system. High-impact materials — those that contact the product or affect critical process parameters — warrant deeper characterization. Lower-risk inputs still require traceability and periodic review, but the depth of qualification can be scaled appropriately.

Verta supports sponsors in structuring raw material strategies from early development through commercial supply. For guidance on qualification planning, supplier management, or regulatory preparation, contact our team.